SCHEMBL3346136

SCHEMBL3346136

Cc1ncn(-c2ccc(C)c(N)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
CASP1 P29466 1/20 0.39
NPC1 O15118 6/20 0.39
RAB9A P51151 5/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
MCL1 Q07820 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPK10 P53779 4/20 0.38
ATM Q13315 1/20 0.37
CYP3A4 P08684 3/20 0.37
PSEN1 P49768 3/20 0.36
PSEN2 P49810 3/20 0.36
APH1B Q8WW43 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16202005 0.79 NOTUM (0.44) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL719952 0.78 MAPK10 (0.42) MEN1KMT2AMAPTKDM4EALDH1A1
Hydrochloric Acid SCHEMBL5799102 0.77 MAPK10 (0.41) MEN1KMT2AMAPTKDM4ENPSR1
SCHEMBL3346133 0.76 SIRT3 (0.38) MEN1KMT2AMAPTALDH1A1TDP1
SCHEMBL22198927 0.76 RXRA (0.43) MAPK10CYP3A4PSEN1PSEN2APH1B
SCHEMBL7127572 0.76 MAPT (0.49) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL31402279 0.76 PSEN1 (0.37) MAPTALDH1A1NPC1RAB9AMAPK10
SCHEMBL16202026 0.74 NOTUM (0.56) GAAMAPK10CYP3A4PSEN1PSEN2
SCHEMBL3703711 0.74 NOS3 (0.44) MAPTKDM4ESMN1; SMN2MAPK10CYP3A4
SCHEMBL13183810 0.74 ALDH1A1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 MEN1 2632/4885KMT2A 3250/4885MAPT 2598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.